News from endo pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ENDP)

Jul 07, 2014, 07:00 ET

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain

 Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences...

Apr 09, 2014, 07:00 ET

Louis Van Amstel, Former Dancing with the Stars Professional, Joins "Making Your Move" Campaign to Raise Awareness of Osteoarthritis

 Emmy-nominated choreographer, nine-time Dancing with the Stars professional and creator of LaBlast dance fitness program Louis...

Mar 06, 2014, 07:00 ET

U.S. FDA Approves AVEED™ (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T

Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that its operating company Endo Pharmaceuticals Inc. received U.S. Food and...

Feb 21, 2014, 12:49 ET

Endo Announces Resolution of Government Investigation

Endo Pharmaceuticals, a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), announced today that it has reached a resolution of criminal and...

Feb 20, 2014, 14:00 ET

Endo to Announce Fourth Quarter 2013 Financial Results on February 28, 2014

 Endo Health Solutions (Nasdaq: ENDP) will announce its fourth quarter 2013 financial results before the open of the U.S. financial markets on...

Jan 23, 2014, 16:30 ET

Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq:...

Sep 05, 2013, 08:01 ET

FDA Accepts Endo's Complete Response Submission to New Drug Application for AVEED™ (Testosterone Undecanoate) Injection

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug...

Sep 04, 2013, 06:00 ET

Endo and BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Development Program

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq:...

May 30, 2013, 16:17 ET

Endo Pharmaceuticals Provides Regulatory Update On AVEED™ (Testosterone Undecanoate) Injection

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug...

Oct 04, 2012, 07:00 ET

Endo Health Solutions Will Detail Long-Term Strategy At 2012 Investor Day

- Highlights long-term growth drivers and investment attributes of the company - Endo updates 2012 performance, reaffirms full year...

Sep 26, 2012, 16:10 ET

Endo Health Solutions Announces Receipt of Paragraph IV Certifications for OPANA® ER

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions (Nasdaq: ENDP), announced today that the company has received Paragraph IV...

Sep 06, 2012, 08:30 ET

Endo Pharmaceuticals Announces Reformulated Version of OPANA® ER with INTAC® Technology Designed to be Crush-Resistant Accounts for more than 90 Percent of OPANA ER Total Prescription Volume

Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), today announced that, according to the latest IMS data...

May 23, 2012, 14:00 ET

Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc.

Shareholders of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) voted today at its annual shareholders meeting to approve changing the company's...

May 04, 2012, 10:00 ET

Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference

Endo (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the...

Apr 17, 2012, 09:00 ET

Endo Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 1, 2012

Endo Pharmaceuticals Holdings (Nasdaq: ENDP) will announce its first quarter 2012 financial results on May 1, 2012 and will host a conference call...

Mar 29, 2012, 13:30 ET

Endo Announces Departure of American Medical Systems President

Endo (Nasdaq: ENDP) announced today that American Medical Systems' (AMS) Group President, Tony Bihl, will step down as head of the Endo devices...

Mar 13, 2012, 08:30 ET

Endo Files Amended Citizen Petition Seeking Public FDA Resolution of Several Safety and Efficacy Issues Prior to Approval of a Generic Formulation of LIDODERM®

 Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has filed an amendment to its Citizen Petition (CP) with the U.S. Food and Drug...

Mar 01, 2012, 08:30 ET

Endo Pharmaceuticals Announces Proposal to Change Name of Parent Company and Rebrands Enterprise: Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value

Endo (Nasdaq: ENDP), a diversified healthcare solutions company, today announced the aggregation of its operating companies as part of an...

Feb 24, 2012, 07:00 ET

Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance

Endo Pharmaceuticals (Nasdaq: ENDP) today reported financial results for the fourth quarter of 2011. Total revenues during the fourth quarter of...

Feb 22, 2012, 16:30 ET

Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference

 Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate...